Vicarious Surgical Inc. (RBOT) 10-Year Financial Performance & Capital Metrics

RBOT • • Industrial / General

HealthcareMedical DevicesSurgical & Minimally Invasive DevicesSurgical Energy & Ablation Systems

AboutVicarious Surgical Inc. engages in developing and selling single-incision surgical robot that virtually transports surgeons inside the patient to perform minimally invasive surgery. It offers Vicarious System, a single-incision surgical robot for ventral hernia repair. The company was incorporated in 2014 and is headquartered in Waltham, Massachusetts.Show more

Revenue $0
EBITDA -$64M +18.2%
Net Income -$63M +11.0%
EPS (Diluted) -10.72 +26.6%
Gross Margin -
EBITDA Margin -
Operating Margin -
Net Margin -
ROE -87.4% -28.5%
ROIC -90.16% +47.5%
Debt/Equity 0.30 +95.0%
Interest Coverage -

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓Trading at only 0.4x book value

✗Weaknesses

✗Weak Piotroski F-Score: 1/9
✗Weak momentum: RS Rating 4 (bottom 4%)
✗Shares diluted 20.9% in last year
✗Trading more than 30% below 52-week high
✗Low asset turnover indicates capital-intensive operations

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y-

5Y-

3Y-

TTM-

Profit (Net Income) CAGR

10Y-

5Y-

3Y-

TTM14.12%

EPS CAGR

10Y-

5Y-

3Y-

TTM17.05%

ROCE

10Y Avg-62.74%

5Y Avg-62.86%

3Y Avg-65.07%

Latest-77.1%

Peer Comparison

Surgical Energy & Ablation Systems

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	Debt/Equity
BDMDBaird Medical Investment Holdings Limited	47.38M	1.29	2.63	17.74%	33.62%	33%	0.53
IVFINVO Fertility, Inc.	12.26M	0.81	-0.03	116.25%	-417.01%	-495.09%	0.78
AEMDAethlon Medical, Inc.	2.55M	2.62	-0.03			-0.2%	0.13
HYPDHyperion DeFi, Inc.	29.01M	3.55	-0.06	14.14%	-73.86%	-36.05%
NAOVNanoVibronix, Inc.	1.85M	1.70	-0.12	12.05%	-133.04%	-8.41%	0.19
ALURAllurion Technologies Inc.	21.55M	1.76	-0.15	-39.94%	-251.56%
RBOTVicarious Surgical Inc.	18.23M	2.82	-0.26			-380.42%	0.30
TELATELA Bio, Inc.	44.98M	1.01	-0.76	18.56%	-50.61%	-25.05%	1.51

Profit & Loss

	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Sales/Revenue+	0	0	0	0	0	0
Revenue Growth %	-	-	-	-	-	-
Cost of Goods Sold+	0	0	0	0	1.85M	2.11M
COGS % of Revenue	-	-	-	-	-	-
Gross Profit+	0	0	0	0	-1.85M	-2.11M
Gross Margin %	-	-	-	-	-	-
Gross Profit Growth %	-	-	-	-	-	-0.14%
Operating Expenses+	9.78M	12.98M	38.22M	80.08M	78.81M	64.45M
OpEx % of Revenue	-	-	-	-	-	-
Selling, General & Admin	2.3M	3.19M	16.16M	36.18M	33.09M	26.4M
SG&A % of Revenue	-	-	-	-	-	-
Research & Development	7.48M	9.8M	22.06M	43.9M	47.58M	40.16M
R&D % of Revenue	-	-	-	-	-	-
Other Operating Expenses	0	0	0	0	-1.85M	-2.11M
Operating Income+	-9.78M	-12.98M	-38.22M	-80.08M	-80.67M	-66.56M
Operating Margin %	-	-	-	-	-	-
Operating Income Growth %	-	-0.33%	-1.94%	-1.1%	-0.01%	0.17%
EBITDA+	-9.68M	-12.83M	-37.91M	-78.97M	-78.81M	-64.45M
EBITDA Margin %	-	-	-	-	-	-
EBITDA Growth %	-	-0.33%	-1.96%	-1.08%	0%	0.18%
D&A (Non-Cash Add-back)	104K	157K	316K	1.11M	1.85M	2.11M
EBIT	-9.78M	-12.98M	-35.12M	5.36M	-71.05M	-63.22M
Net Interest Income+	469	110K	-69K	1.24M	4.4M	3.29M
Interest Income	469	113K	20K	1.44M	4.43M	3.29M
Interest Expense	0	3K	89K	200K	25K	0
Other Income/Expense	469K	110K	3.02M	85.23M	9.6M	3.33M
Pretax Income+	-9.31M	-12.88M	-35.21M	5.16M	-71.07M	-63.22M
Pretax Margin %	-	-	-	-	-	-
Income Tax+	0	0	0	0	0	0
Effective Tax Rate %	1%	1%	1%	1%	1%	1%
Net Income+	-9.31M	-12.88M	-35.21M	5.16M	-71.07M	-63.22M
Net Margin %	-	-	-	-	-	-
Net Income Growth %	-	-0.38%	-1.73%	1.15%	-14.78%	0.11%
Net Income (Continuing)	-9.31M	-12.88M	-35.21M	5.16M	-71.07M	-63.22M
Discontinued Operations	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0
EPS (Diluted)+	-1.70	-3.76	-10.92	1.21	-14.60	-10.72
EPS Growth %	-	-1.21%	-1.9%	1.11%	-13.07%	0.27%
EPS (Basic)	-1.70	-3.76	-10.92	1.27	-14.70	-10.72
Diluted Shares Outstanding	5.47M	3.42M	3.22M	4.25M	4.87M	5.89M
Basic Shares Outstanding	5.46M	3.42M	3.22M	4.29M	4.83M	5.89M
Dividend Payout Ratio	-	-	-	-	-	-

Balance Sheet

	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Current Assets+	15.73M	17.13M	178.37M	120.4M	100.95M	51.7M
Cash & Short-Term Investments	15.48M	16.87M	173.51M	116.21M	98.18M	49.1M
Cash Only	2.16M	16.87M	173.51M	116.21M	52.82M	9.74M
Short-Term Investments	13.32M	0	0	0	45.35M	39.36M
Accounts Receivable	0	0	0	0	0	0
Days Sales Outstanding	-	-	-	-	-	-
Inventory	0	0	0	0	0	0
Days Inventory Outstanding	-	-	-	-	-	-
Other Current Assets	255K	0	0	4.2M	2.78M	2.6M
Total Non-Current Assets+	630K	663K	3.31M	19.89M	18.91M	16.02M
Property, Plant & Equipment	482K	445K	2.25M	18.86M	17.86M	15.04M
Fixed Asset Turnover	-	-	-	-	-	-
Goodwill	0	0	0	0	0	0
Intangible Assets	0	0	0	0	0	0
Long-Term Investments	0	345.19M	0	936K	0	0
Other Non-Current Assets	148K	-344.97M	1.05M	92K	1.05M	985K
Total Assets+	16.36M	17.79M	181.68M	140.29M	119.86M	67.72M
Asset Turnover	-	-	-	-	-	-
Asset Growth %	-	0.09%	9.21%	-0.23%	-0.15%	-0.44%
Total Current Liabilities+	622K	814K	6.25M	8.39M	7.28M	7.67M
Accounts Payable	203K	373K	1.5M	1.73M	1.26M	1.17M
Days Payables Outstanding	-	-	-	-	247.66	201.99
Short-Term Debt	47K	47K	647K	16K	0	0
Deferred Revenue (Current)	0	0	0	0	0	0
Other Current Liabilities	372K	291K	0	0	4.06M	3.97M
Current Ratio	25.30x	21.04x	28.56x	14.35x	13.87x	6.74x
Quick Ratio	25.30x	21.04x	28.56x	14.35x	13.87x	6.74x
Cash Conversion Cycle	-	-	-	-	-	-
Total Non-Current Liabilities+	111K	121K	92.34M	20.85M	14.62M	13.35M
Long-Term Debt	111K	63K	691K	0	0	0
Capital Lease Obligations	0	0	0	14.83M	13.79M	12.57M
Deferred Tax Liabilities	0	-12.07M	0	0	0	0
Other Non-Current Liabilities	0	58K	91.65M	6.02M	830K	787K
Total Liabilities	733K	935K	98.59M	29.25M	21.89M	21.02M
Total Debt+	158K	110K	1.34M	15.69M	14.83M	13.79M
Net Debt	-2M	-16.76M	-172.17M	-100.52M	-37.99M	4.05M
Debt / Equity	0.01x	0.01x	0.02x	0.14x	0.15x	0.30x
Debt / EBITDA	-	-	-	-	-	-
Net Debt / EBITDA	-	-	-	-	-	-
Interest Coverage	-	-4328.33x	-429.47x	-400.39x	-3226.64x	-
Total Equity+	15.63M	16.85M	83.09M	111.05M	97.97M	46.7M
Equity Growth %	-	0.08%	3.93%	0.34%	-0.12%	-0.52%
Book Value per Share	2.86	4.92	25.80	26.15	20.13	7.93
Total Shareholders' Equity	15.63M	16.85M	83.09M	111.05M	97.97M	46.7M
Common Stock	1K	9K	12K	13K	17K	17K
Retained Earnings	-18.72M	-31.59M	-66.8M	-61.64M	-132.71M	-195.94M
Treasury Stock	0	0	0	0	0	0
Accumulated OCI	0	-329.22M	0	0	10K	50K
Minority Interest	0	0	0	0	0	0

Cash Flow

	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Cash from Operations+	-8.71M	-12.04M	-33.3M	-61.21M	-62.3M	-49.96M
Operating CF Margin %	-	-	-	-	-	-
Operating CF Growth %	-	-0.38%	-1.77%	-0.84%	-0.02%	0.2%
Net Income	-9.31M	-12.88M	-35.21M	5.16M	-71.07M	-63.22M
Depreciation & Amortization	104K	157K	316K	1.11M	1.85M	2.11M
Stock-Based Compensation	337K	448K	3.69M	12.26M	13.27M	11.9M
Deferred Taxes	0	188.07K	-3.08M	0	0	0
Other Non-Cash Items	64K	-188.07K	21K	-83.1M	-5.61M	-150K
Working Capital Changes	98K	232K	955K	3.36M	-746K	-594K
Change in Receivables	0	0	0	0	0	0
Change in Inventory	0	0	0	0	0	0
Change in Payables	0	170K	1.13M	135K	-473K	-96K
Cash from Investing+	-1.85M	13.2M	-1.29M	-5.35M	-45.78M	6.86M
Capital Expenditures	-246K	-120K	-1.29M	-5.35M	-1.67M	-180K
CapEx % of Revenue	-	-	-	-	-	-
Acquisitions	-	-	-	-	-	-
Investments	-	-	-	-	-	-
Other Investing	-1.6M	13.32K	0	0	0	0
Cash from Financing+	10M	13.52M	192.16M	9.14M	44.7M	8K
Debt Issued (Net)	-	-	-	-	-	-
Equity Issued (Net)	-	-	-	-	-	-
Dividends Paid	0	0	0	0	0	0
Share Repurchases	-	-	-	-	-	-
Other Financing	10.03M	43K	190.86M	542K	-2.53M	0
Net Change in Cash	-	-	-	-	-	-
Free Cash Flow+	-8.96M	-12.16M	-34.59M	-66.56M	-63.98M	-50.14M
FCF Margin %	-	-	-	-	-	-
FCF Growth %	-	-0.36%	-1.84%	-0.92%	0.04%	0.22%
FCF per Share	-1.64	-3.55	-10.74	-15.67	-13.14	-8.52
FCF Conversion (FCF/Net Income)	0.94x	0.93x	0.95x	-11.87x	0.88x	0.79x
Interest Paid	2K	3K	36K	41K	1K	0
Taxes Paid	0	0	0	0	0	0

Key Ratios

Metric	2019	2020	2021	2022	2023	2024
Return on Equity (ROE)	-59.58%	-79.27%	-70.45%	5.31%	-68.01%	-87.4%
Return on Invested Capital (ROIC)	-	-141.86%	-	-	-171.62%	-90.16%
Debt / Equity	0.01x	0.01x	0.02x	0.14x	0.15x	0.30x
Interest Coverage	-	-4328.33x	-429.47x	-400.39x	-3226.64x	-
FCF Conversion	0.94x	0.93x	0.95x	-11.87x	0.88x	0.79x

Frequently Asked Questions

Growth & Financials

Vicarious Surgical Inc. (RBOT) grew revenue by 0.0% over the past year. Growth has been modest.

Vicarious Surgical Inc. (RBOT) reported a net loss of $53.6M for fiscal year 2024.

Dividend & Returns

Vicarious Surgical Inc. (RBOT) has a return on equity (ROE) of -87.4%. Negative ROE indicates the company is unprofitable.

Vicarious Surgical Inc. (RBOT) had negative free cash flow of $47.8M in fiscal year 2024, likely due to heavy capital investments.

← Back to Screener